Editing Human genetics (TRPM7)

{{tp|p=36095216|t=2022. A TRPM7 mutation linked to familial trigeminal neuralgia: Omega current and hyperexcitability of trigeminal ganglion neurons.|pdf=|usr=}}{{36095216}}
{{tp|p=35561741|t=2023. Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia.|pdf=|usr=}}{{35561741}}
{{tp|p=31423533|t=2020. Genetic variants in TRPM7 associated with unexplained stillbirth modify ion channel function.|pdf=|usr=}}{{31423533}}
{{tp|p=18227801|t=2008. Hereditary etiologies of hypomagnesemia.|pdf=|usr=}}{{18227801}}
{{tp|p=19149903|t=2009. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women.|pdf=|usr=}}{{19149903}}
{{tp|p=16051700|t=2005. A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders.|pdf=|usr=}}{{16051700}}
{{tp|p=18448590|t=2008. Human FXYD2 G41R mutation responsible for renal hypomagnesemia behaves as an inward-rectifying cation channel.|pdf=|usr=}}{{18448590}}
{{tp|p=26273099|t=2015. Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6.|pdf=|usr=}}{{26273099}}
{{tp|p=25313976|t=2014. X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect.|pdf=|usr=}}{{25313976}}
{{tp|p=31207912|t=2019. Magnesium Supplement and the 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: A Potential Treatment?|pdf=|usr=}}{{31207912}}
{{tp|p=34784661|t=2021. Hereditary kidney diseases associated with hypomagnesemia.|pdf=|usr=}}{{34784661}}
{{tp|p=29344503|t=2017. Genetics of Magnesium Disorders.|pdf=|usr=}}{{29344503}}
{{tp|p=25733456|t=2015. Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and Hispanic American women.|pdf=|usr=}}{{25733456}}
{{tp|p=24322525|t=2013. Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge.|pdf=|usr=}}{{24322525}}
{{tp|p=20700443|t=2010. Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels.|pdf=|usr=}}{{20700443}}
{{tp|p=34578838|t=2021. The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman's and Bartter's Syndromes.|pdf=|usr=}}{{34578838}}
{{tp|p=33159963|t=2021. Targeting fibroblast growth factor 23-responsive pathways uncovers controlling genes in kidney mineral metabolism.|pdf=|usr=}}{{33159963}}
{{tp|p=32302086|t=2021. Treatment Difficulties in Hypomagnesemia Secondary to the Transient Receptor Potential Melastatin 6 Gene: A Case Report with Novel Mutation.|pdf=|usr=}}{{32302086}}
{{tp|p=31993563|t=2019. Genome-wide Association Study of 24-Hour Urinary Excretion of Calcium, Magnesium, and Uric Acid.|pdf=|usr=}}{{31993563}}
{{tp|p=27234911|t=2017. Genetic causes of hypomagnesemia, a clinical overview.|pdf=|usr=}}{{27234911}}
{{tp|p=26759217|t=2016. A Novel Homozygous Mutation in the Transient Receptor Potential Melastatin 6 Gene: A Case Report.|pdf=|usr=}}{{26759217}}
{{tp|p=18818955|t=2009. Inherited forms of renal hypomagnesemia: an update.|pdf=|usr=}}{{18818955}}